Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency

Acta Myologica

Volumn 26, Issue 1, 2007, Pages 72-74

  Lucchiari, S ^a   Santoro, D ^a   Pagliarani, S ^a   Comi, Giacomo P ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

AGL; Glycogen storage disease; Metabolic myopathy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLYCOGEN; GLYCOGEN DEBRANCHING ENZYME;

ALLELE; BIOACCUMULATION; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GLYCOGEN STORAGE DISEASE TYPE 3; HUMAN; ITALY; LIVER INJURY; MUSCLE WEAKNESS; PHENOTYPE; PROTEIN DIET; REVIEW;

DIET; FEMALE; GENOTYPE; GLYCOGEN DEBRANCHING ENZYME SYSTEM; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; ITALY; MALE; PHENOTYPE;

EID: 34548637364     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Illingworth B, Cori GT. Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen. J Biol Chem 1952;199:653-60.
2. Forbes GB. Glycogen storage disease; report of a case with abnormal glycogen structure in liver and skeletal muscle. J Pediatr 1953;42:645-53.
3. Yang-Feng TL, Zheng K, Yu J, Yang BZ, Chen YT, Kao FT. Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics 1992;13:931-4.
4. Haagsma EB, Smit GP, Niezen-Koning KE, et al. The Liver Transplant Group. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. Hepatology 1997;25:537-40.
5. Gordon RB, Brown DH, Brown BI. Preparation and properties of the glycogen-debranching enzyme from rabbit liver. Biochim Biophys Acta 1972;289:97-107.
6. Bates EJ, Heaton GM, Taylor C, Kernohan JC, Cohen P. Debranching enzyme from rabbit skeletal muscle; evidence for the location of two active centres on a single polypeptide chain. FEBS Lett 1975;58:181-5.
7. Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352-7.
8. Campanaro S, Romualdi C, Fanin M, et al. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet 2002;11:3283-98.
9. Hadjigeorgiou GM, Comi GP, Bordoni A, et al. Novel donor splice site mutations of AGL gene in glycogen storage disease type IIIa. J Inherit Metab Dis 1999;22:762-3.
10. Lucchiari S, Donati MA, Parini R, et al. Molecular characterization of GSD III subjects and identification of six novel mutations in AGL. Hum Mutat 2002;20:480.
11. Slonim AE, Coleman RA, Moses WS. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 1984;105:906-11.